Epilepsia Open (Feb 2024)
Intracerebral electrographic activity following a single dose of diazepam nasal spray: A pilot study
Abstract
Abstract Objective Rescue benzodiazepine medication can be used to treat seizure clusters, which are intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient's usual seizure pattern. The NeuroPace RNS® System is a device that detects abnormal electrographic activity through intracranial electrodes and administers electrical stimulation to control seizures. Reductions in electrographic activity over days to weeks have been associated with the longer‐term efficacy of daily antiseizure medications (ASMs). In this pilot study, electrographic activity over hours to days was examined to assess the impact of a single dose of a proven rescue therapy (diazepam nasal spray) with a rapid onset of action. Methods Adult volunteers (>18 years old) with clinically indicated RNS (stable settings and ASM usage) received a weight‐based dose of diazepam nasal spray in the absence of a clinical seizure. Descriptive statistics for a number of detections and a sum of durations of detections at 10‐min, hourly, and 24‐h intervals during the 7‐day (predose) baseline period were calculated. Post‐dose detections at each time interval were compared with the respective baseline‐detection intervals using a 1 SD threshold. The number of long episodes that occurred after dosing also were compared with the baseline. Results Five participants were enrolled, and four completed the study; the excluded participant had recurrent seizures during the study. There were no consistent changes (difference >1 SD) in detections between post‐dose and mean baseline values. Although variability was high (1 SD was often near or exceeded the mean), three participants showed possible trends for reductions in one or more electrographic variables following treatment. Significance RNS‐assessed electrographic detections and durations were not shown to be sensitive measures of short‐term effects associated with a single dose of rescue medication in this small group of participants. The variability of detections may have masked a measurable drug effect. Plain Language Summary Rescue drugs are used to treat seizure clusters. Responsive neurostimulation (RNS) devices detect and record epilepsy brain waves and then send a pulse to help stop seizures. This pilot study looked at whether one dose of a rescue treatment changes brain activity detected by RNS. There was a very wide range of detections, which made it difficult to see if or how the drug changed brain activity. New studies should look at other types of brain activity, multiple doses, and larger patient groups.
Keywords
